Researchers' views on turning psychedelic studies into medical treatments

Twenty-one clinical investigators identified three major challenges for integrating psychedelic medicine into routine clinical care.

• Psychedelic treatments are perceived as distinct from existing therapies in their effects and treatment models.
• There is uncertainty regarding the necessity and role of psychotherapy in conjunction with psychedelic treatments.
• The cost and scalability of psychedelic treatments may hinder their widespread adoption.
• Investigators expressed concerns about how hype and stigma could affect the uptake of psychedelic medicines in clinical settings.
• Despite these challenges, there is a belief that psychedelic medicine could eventually be integrated into standard care.

Simplified